Verona Pharma (VRNA) News Today $64.51 +0.33 (+0.51%) Closing price 04:00 PM EasternExtended Trading$65.00 +0.49 (+0.76%) As of 05:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Verona Pharma plc (NASDAQ:VRNA) Given Consensus Rating of "Buy" by BrokeragesVerona Pharma plc (NASDAQ:VRNA - Get Free Report) has been given a consensus rating of "Buy" by the seven ratings firms that are covering the stock, MarketBeat reports. Six equities research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation tMarch 27 at 2:22 AM | marketbeat.comJim Cramer Advises Caution on Verona Pharma (VRNA): “Risky – Sell Half and Let the Rest Ride”March 26 at 5:23 PM | insidermonkey.comVerona Pharma (NASDAQ:VRNA) Shares Down 2% - Should You Sell?Verona Pharma (NASDAQ:VRNA) Stock Price Down 2% - What's Next?March 25 at 12:26 PM | marketbeat.comRosalind Advisors Inc. Has $6.97 Million Stock Holdings in Verona Pharma plc (NASDAQ:VRNA)Rosalind Advisors Inc. reduced its holdings in Verona Pharma plc (NASDAQ:VRNA - Free Report) by 45.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 150,000 shares of the company's stock after selling 125,March 23, 2025 | marketbeat.comVerona Pharma plc (NASDAQ:VRNA) Shares Purchased by EverSource Wealth Advisors LLCEverSource Wealth Advisors LLC raised its stake in Verona Pharma plc (NASDAQ:VRNA - Free Report) by 3,074.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,158 shares of the company's stock afMarch 16, 2025 | marketbeat.comM&T Bank Corp Makes New $243,000 Investment in Verona Pharma plc (NASDAQ:VRNA)M&T Bank Corp bought a new position in shares of Verona Pharma plc (NASDAQ:VRNA - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 5,243 shares of the company's stock, valued at approximately $243,000.March 16, 2025 | marketbeat.comVerona Pharma (NASDAQ:VRNA) Shares Gap Down on Insider SellingVerona Pharma (NASDAQ:VRNA) Shares Gap Down After Insider SellingMarch 15, 2025 | marketbeat.comHBK Sorce Advisory LLC Increases Position in Verona Pharma plc (NASDAQ:VRNA)HBK Sorce Advisory LLC increased its stake in shares of Verona Pharma plc (NASDAQ:VRNA - Free Report) by 387.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 35,814 shares of the company's stock after buyingMarch 15, 2025 | marketbeat.comAtria Investments Inc Has $642,000 Holdings in Verona Pharma plc (NASDAQ:VRNA)Atria Investments Inc trimmed its holdings in Verona Pharma plc (NASDAQ:VRNA - Free Report) by 27.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,833 shares of the company's stockMarch 15, 2025 | marketbeat.comKathleen A. Rickard Sells 79,264 Shares of Verona Pharma plc (NASDAQ:VRNA) StockVerona Pharma plc (NASDAQ:VRNA - Get Free Report) insider Kathleen A. Rickard sold 79,264 shares of the company's stock in a transaction that occurred on Wednesday, March 12th. The stock was sold at an average price of $8.35, for a total value of $661,854.40. Following the completion of the sale, the insider now owns 2,608,976 shares in the company, valued at approximately $21,784,949.60. This represents a 2.95 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.March 14, 2025 | marketbeat.comIs Verona Pharma plc (VRNA) the Best Performing Growth Stock in 2025?March 14, 2025 | msn.comVerona Pharma: Great Year For Share Price, But Competition Threatens Bull ThesisMarch 13, 2025 | seekingalpha.comVerona Pharma (NASDAQ:VRNA) Trading Up 5.8% - Should You Buy?Verona Pharma (NASDAQ:VRNA) Trading Up 5.8% - Time to Buy?March 13, 2025 | marketbeat.comUS Bancorp DE Has $401,000 Stake in Verona Pharma plc (NASDAQ:VRNA)US Bancorp DE decreased its holdings in Verona Pharma plc (NASDAQ:VRNA - Free Report) by 60.7% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 8,627 shares of the company's stock after selling 13,328 shares durMarch 13, 2025 | marketbeat.comPersonal CFO Solutions LLC Makes New $284,000 Investment in Verona Pharma plc (NASDAQ:VRNA)Personal CFO Solutions LLC bought a new stake in shares of Verona Pharma plc (NASDAQ:VRNA - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 6,109 shares of the company's stock, valued at approximately $284,000. SeMarch 11, 2025 | marketbeat.comKeybank National Association OH Acquires Shares of 6,460 Verona Pharma plc (NASDAQ:VRNA)Keybank National Association OH acquired a new stake in shares of Verona Pharma plc (NASDAQ:VRNA - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 6,460 shares of the company's stock, valued at approximatelyMarch 11, 2025 | marketbeat.comVerona Pharma management to meet with TruistMarch 7, 2025 | markets.businessinsider.comCandriam S.C.A. Lowers Stake in Verona Pharma plc (NASDAQ:VRNA)Candriam S.C.A. cut its stake in Verona Pharma plc (NASDAQ:VRNA - Free Report) by 43.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 440,313 shares of the company's stock after selling 332,684 sharMarch 7, 2025 | marketbeat.comNew York State Common Retirement Fund Makes New $285,000 Investment in Verona Pharma plc (NASDAQ:VRNA)New York State Common Retirement Fund bought a new stake in Verona Pharma plc (NASDAQ:VRNA - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 6,143 shares of the company's stock, valued at approximately $285,0March 6, 2025 | marketbeat.comBTIG Sticks to Its Buy Rating for Verona Pharma (VRNA)March 5, 2025 | markets.businessinsider.comVerona Pharma plc (VRNA): A Bull Case TheoryMarch 5, 2025 | insidermonkey.comBeat the Market the Zacks Way: Verona, Visa, Starbucks in FocusMarch 3, 2025 | finance.yahoo.comVerona Pharma management to meet with Piper SandlerMarch 3, 2025 | markets.businessinsider.comHC Wainwright Predicts Verona Pharma Q1 EarningsVerona Pharma plc (NASDAQ:VRNA - Free Report) - Analysts at HC Wainwright issued their Q1 2026 earnings per share (EPS) estimates for shares of Verona Pharma in a report released on Friday, February 28th. HC Wainwright analyst R. Selvaraju anticipates that the company will post earnings per shareMarch 3, 2025 | marketbeat.comEarnings Beat: Verona Pharma plc (NASDAQ:VRNA) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their ForecastsMarch 2, 2025 | finance.yahoo.comVerona Pharma plc (NASDAQ:VRNA) Given Average Rating of "Buy" by AnalystsVerona Pharma plc (NASDAQ:VRNA - Get Free Report) has earned an average recommendation of "Buy" from the seven research firms that are currently covering the stock, MarketBeat.com reports. Six analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendationMarch 2, 2025 | marketbeat.comVerona Pharma (NASDAQ:VRNA) Hits New 1-Year High Following Analyst UpgradeVerona Pharma (NASDAQ:VRNA) Hits New 52-Week High Following Analyst UpgradeMarch 1, 2025 | marketbeat.comVerona Pharma (NASDAQ:VRNA) Price Target Raised to $93.00Wells Fargo & Company increased their price objective on shares of Verona Pharma from $74.00 to $93.00 and gave the company an "overweight" rating in a report on Friday.March 1, 2025 | marketbeat.comVerona Pharma price target raised to $75 from $60 at H.C. WainwrightMarch 1, 2025 | markets.businessinsider.comVerona Pharma price target raised to $76 from $57 at TruistMarch 1, 2025 | markets.businessinsider.comVerona Pharma (NASDAQ:VRNA) Stock Price Expected to Rise, HC Wainwright Analyst SaysHC Wainwright boosted their target price on Verona Pharma from $60.00 to $75.00 and gave the stock a "buy" rating in a research report on Friday.March 1, 2025 | marketbeat.comVerona Pharma (NASDAQ:VRNA) Releases Quarterly Earnings Results, Misses Estimates By $0.17 EPSVerona Pharma (NASDAQ:VRNA - Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($0.40) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.23) by ($0.17).February 28, 2025 | marketbeat.comVerona Pharma (NASDAQ:VRNA) Announces Earnings ResultsVerona Pharma (NASDAQ:VRNA - Get Free Report) posted its quarterly earnings data on Thursday. The company reported ($0.40) earnings per share for the quarter, missing the consensus estimate of ($0.23) by ($0.17).February 28, 2025 | marketbeat.comVerona Pharma (NASDAQ:VRNA) Shares Gap Up - Time to Buy?Verona Pharma (NASDAQ:VRNA) Shares Gap Up - Time to Buy?February 28, 2025 | marketbeat.comWells Fargo Remains a Buy on Verona Pharma (VRNA)February 28, 2025 | markets.businessinsider.comVerona Pharma plc (NASDAQ:VRNA) Q4 2024 Earnings Call TranscriptFebruary 28, 2025 | msn.comVerona Pharma PLC (VRNA) Q4 2024 Earnings Call Highlights: Strong Launch of Ohtuvayre Amid ...February 28, 2025 | finance.yahoo.comVerona Pharma plc: Verona Pharma Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate UpdateFebruary 27, 2025 | finanznachrichten.deVerona Pharma plc (VRNA) Q4 2024 Earnings Call TranscriptFebruary 27, 2025 | seekingalpha.comVerona Pharma Reports Strong Launch Momentum for Ohtuvayre with $36.6 Million in Q4 Sales and Expansion of Clinical ProgramsFebruary 27, 2025 | quiverquant.comVerona Pharma Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate UpdateFebruary 27, 2025 | globenewswire.comEarnings To Watch: Verona Pharma PLC (VRNA) Reports Q4 2024 ResultFebruary 26, 2025 | finance.yahoo.comWrapmanager Inc. Takes Position in Verona Pharma plc (NASDAQ:VRNA)Wrapmanager Inc. bought a new position in Verona Pharma plc (NASDAQ:VRNA - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 4,448 shares of the company's stock, valued at approximately $207,000. A number of other lFebruary 26, 2025 | marketbeat.comVerona Pharma (VRNA) Projected to Post Quarterly Earnings on ThursdayVerona Pharma (NASDAQ:VRNA) will be releasing earnings before the market opens on Thursday, February 27. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=666222)February 25, 2025 | marketbeat.comVerona Pharma (VRNA) Receives a Buy from Roth MKMFebruary 24, 2025 | markets.businessinsider.comInvestors Buy High Volume of Verona Pharma Put Options (NASDAQ:VRNA)Verona Pharma plc (NASDAQ:VRNA - Get Free Report) saw unusually large options trading on Monday. Stock investors purchased 3,994 put options on the company. This represents an increase of approximately 120% compared to the average daily volume of 1,816 put options.February 24, 2025 | marketbeat.comTranscend Capital Advisors LLC Invests $225,000 in Verona Pharma plc (NASDAQ:VRNA)Transcend Capital Advisors LLC acquired a new position in Verona Pharma plc (NASDAQ:VRNA - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 4,835 shares of the company's stock, valued at approximately $225,000. Several otherFebruary 24, 2025 | marketbeat.comVerona Pharma plc (VRNA): The Best Performing Pharma Stock So Far in 2025?February 23, 2025 | insidermonkey.comVerona Pharma (NASDAQ:VRNA) Stock Price Up 6.3% - What's Next?Verona Pharma (NASDAQ:VRNA) Trading Up 6.3% - Here's What HappenedFebruary 22, 2025 | marketbeat.comVerona Pharma (VRNA) Projected to Post Earnings on ThursdayVerona Pharma (NASDAQ:VRNA) will be releasing earnings before the market opens on Thursday, February 27. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=666222)February 21, 2025 | marketbeat.com Remove Ads Get Verona Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for VRNA and its competitors with MarketBeat's FREE daily newsletter. Email Address VRNA Media Mentions By Week VRNA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VRNA News Sentiment▼1.010.78▲Average Medical News Sentiment VRNA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VRNA Articles This Week▼55▲VRNA Articles Average Week Remove Ads Get Verona Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for VRNA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TEVA News SMMT News ITCI News MRNA News GMAB News RDY News VTRS News ASND News PCVX News QGEN News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VRNA) was last updated on 3/27/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verona Pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Verona Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VRNA Stock Free VRNA Stock Alerts